Teligent Total Change in Assets/Liabilities 2010-2021 | TLGT
Teligent total change in assets/liabilities from 2010 to 2021. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
Teligent Annual Total Change in Assets/Liabilities
(Millions of US $) |
| 2020 |
$5 |
| 2019 |
$-11 |
| 2018 |
$-7 |
| 2017 |
$2 |
| 2016 |
$-7 |
| 2015 |
$-10 |
| 2014 |
$-9 |
| 2013 |
$-2 |
| 2012 |
$0 |
| 2011 |
$-1 |
| 2010 |
$-1 |
| 2009 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
